We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek!
We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek.
With vast experience in the pharmaceutical industry, he will undoubtedly become a key part of the Quinta team and aid us in our continued growth.
Starting in the industry 30 years ago at the Charles University in Hradec Králové, CZ, he dedicated his career-to-date at Zentiva where he served as a member of the corporate senior management team.
Holding positions of responsibility across Quality, Regulatory, and Pharmacovigilance, he played a key part in the building of a highly renowned quality system and contributed to the Regulatory Affairs function in different stages of Zentiva’s development. Enabling it to grow from a regional player to the global Gx business of Sanofi.
Deeply involved in projects in Europe, Latin America, Southeast Asia & the Middle East throughout his career, he joins QUINTA-ANALYTICA ready to contribute to enhancing our team and ensuring we remain a leading provider of high quality analytical and clinical services for pharmadevelopment and manufacturing.
His experience will further strengthen Quinta and will help power the top-class services we provide globally.
Welcome on-board, Miroslav.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency